Aqr Capital Management LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Aqr Capital Management LLC
- $151 Billion
- Q3 2025
A detailed history of Aqr Capital Management LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 44,606 shares of KALV stock, worth $594,151. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,606
Previous 47,413
5.92%
Holding current value
$594,151
Previous $536,000
0.37%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding KALV
# of Institutions
158Shares Held
58MCall Options Held
1.21MPut Options Held
865K-
Vr Adviser, LLC New York, NY6.73MShares$89.6 Million12.35% of portfolio
-
Tang Capital Management LLC San Diego, CA5.04MShares$67.2 Million2.77% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.04MShares$67.1 Million2.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.77MShares$63.5 Million1.73% of portfolio
-
Capital World Investors Los Angeles, CA3.18MShares$42.3 Million0.01% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $328M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...